Reduced vitamins K are acting as cofactors of glutamic carboxylation of pro
coagulant factors (II, VII, IX and X). The reduction of these vitamins is i
nhibited by oral anticoagulants.
The response to antivitamins K is individual and may change during the trea
tment of a patient. The determinations of plasmatic vitamin K and acenocoum
arol may help to explain the mechanism of a resistance to the anticoagulant
therapy.
Quantifications of vitamin K1 are realized after liquid-liquid extraction w
ith liquid chromatography and fluorescence detection after post-column redu
ction. For acenocoumarol, plasma concentration is measured, after liquid-li
quid extraction, by liquid chromatograph, with ion trap mass spectrometer d
etector.